A retrospective,multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome

Abstract

Objective

The objective of this report is to investigate the prognostic value of minor salivary glands (MSG) assessment, routinely performed with hematoxilin-eosin (H&E) staining, for the diagnosis of primary Sjögren’s syndrome (pSS).

Methods

We retrospectively evaluated clinical, serological and histological features of 794 pSS patients. H&E-stained sections were assessed using the Chisholm and Mason grading system and/or the focus score (FS).

Results

FS allowed the identification of a number of differences in the disease spectrum, and its prognostic role was further confirmed by quantifying the association between FS value and clinical/serological variables with binary logistic regression. Moreover, hypocomplementemia and FS resulted the only variables associated with lymphoma at univariate analysis, and FS appeared to be associated with lymphoma independently on complement fraction concentrations. Conversely, when patients were divided according to the Chisholm and Mason grading system, we failed to observe any significant difference between subgroups.

Conclusion

In addition to its diagnostic role, our data seem to support that the routine assessment of MSG-FS with H&E staining is useful to predict at the time of diagnosis the adverse outcomes, such as lymphoma and extraglandular manifestations, that complicate the pSS course. On this basis, it should be recommended that an MSG biopsy be performed even in those patients displaying clinical and serological criteria, allowing the diagnosis of pSS independent of histological status.

Keywords

Primary Sjögren’s syndrome minor salivary gland biopsy focus score Chisholm and Mason grading system lymphoma

Get full access to this article

View all access options for this article.

References

Brito-Zerón

Ramos-Casals

. Advances in the understanding and treatment of systemic complications in Sjögren syndrome. Curr Opin Rheumatol 2014; 26: 520–527.

Liang

Yang

Qin

Zhong

. Primary Sjogren’s syndrome and malignancy risk: A systematic review and meta-analysis. Ann Rheum Dis 2014; 73: 1151–1156.

Voulgarelis

Tzioufas

. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren’s syndrome. Nat Rev Rheumatol 2010; 6: 529–537.

Tatouli

Tzioufas

. Pathogenetic aspects of humoral autoimmunity in Sjögren’s syndrome. Lupus 2012; 21: 1151–1154.

Quartuccio

Salvin

Fabris

. BLyS upregulation in Sjogren’s syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands. Rheumatology (Oxford) 2013; 52: 276–281.

Vitali

Bombardieri

Jonsson

. European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjögren’s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554–558.

Shiboski

Criswell

. Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjögren’s syndrome: A data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012; 64: 475–487.

Guellec

Cornec

Jousse-Joulin

. Diagnostic value of labial minor salivary gland biopsy for Sjögren’s syndrome: A systematic review. Autoimmun Rev 2013; 12: 416–420.

Risselada

Kruize

Goldschmeding

. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome. Ann Rheum Dis 2014; 73: 1537–1540.

10.

Carubbi F, Alunno A, Cipriani P, et al. Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren’s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study. Semin Arthritis Rheum. Epub ahead of print 15 May 2014. DOI:10.1016/j.semarthrit.2014.05.015.

11.

Theander

Vasaitis

Baecklund

. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren’s syndrome. Ann Rheum Dis 2011; 70: 1363–1368.

12.

Chisholm

Mason

. Labial salivary gland biopsy in Sjögren’s disease. J Clin Pathol 1968; 21: 656–660.

13.

Daniels

Whitcher

. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren’s syndrome. Arthritis Rheum 1994; 37: 869–877.

14.

Baldini

Pepe

Quartuccio

. Primary Sjogren’s syndrome as a multi-organ disease: Impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) 2014; 53: 839–844.

15.

Priori

Gattamelata

Modesti

. Outcome of pregnancy in Italian patients with primary Sjögren syndrome. J Rheumatol 2013; 40: 1143–1147.

16.

Quartuccio

Isola

Baldini

. Biomarkers of lymphoma in Sjögren’s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: Results of a multicenter study. J Autoimmun 2014; 51: 75–80.

17.

Tavoni

Baldini

Bencivelli

. Italian Study Group on Sjögren’s Syndrome of the Italian Society of Rheumatology. Minor salivary gland biopsy and Sjögren’s syndrome: Comparative analysis of biopsies among different Italian rheumatologic centers. Clin Exp Rheumatol 2012; 30: 929–933.